Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Muhammad Kashif

4PUBLICATIONS

11CO-AUTHORS

Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Nov 03, 2023

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.

Hareth Nahi, Gabriel Afram, Katarina Uttervall

|Sep 06, 2022

Conditioning with melphalan 200 mg/m<sup>2</sup> and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Gabriel Afram, Roza Chaireti, Katarina Uttervall

|Sep 15, 2021

Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.

Sandra Lockmer, Katarina Uttervall, Muhammad Kashif

|Apr 26, 2021

Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).

Hareth Nahi, Muhammad Kashif, Monika Klimkowska

Pageof 1

Frequent Collaborators

1 joint publications

Charlotte Gran

1 joint publications

Robert Månsson

1 joint publications

Gabriel Afram

1 joint publications

Roza Chaireti

1 joint publications

Katarina Uttervall

1 joint publications

Vincent Luong

1 joint publications

Johan Lund

1 joint publications

Gösta Gahrton

1 joint publications

Evren Alici

1 joint publications

Hareth Nahi

Frequent Collaborators

1 joint publications

Charlotte Gran

1 joint publications

Robert Månsson

1 joint publications

Gabriel Afram

1 joint publications

Roza Chaireti

Top Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

See more related videos

Top Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on : Mar 05, 2018

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on : Sep 15, 2023

See more related videos